Biogen Inc. buy Cantor Fitzgerald
Start price
20.02.24
/
50%
€200.60
Target price
20.02.25
€287.58
Performance (%)
-35.17%
End price
21.02.25
€130.05
Summary
This prediction ended on 21.02.25 with a price of €130.05. Massive losses of -35.17% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.525% | 0.525% | 57.143% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten